Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.
2.

Study protocol: the DESPATCH study: delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcare.

Gattellari M, Leung DY, Ukoumunne OC, Zwar N, Grimshaw J, Worthington JM.

Implement Sci. 2011 May 20;6:48. doi: 10.1186/1748-5908-6-48.

3.

Primary Care Atrial Fibrillation Service: outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UK.

Das M, Panter L, Wynn GJ, Taylor RM, Connor N, Mills JD, Kirchhof P, Gupta D.

BMJ Open. 2015 Dec 9;5(12):e009267. doi: 10.1136/bmjopen-2015-009267.

4.

Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.

van Nieuwenhuizen KM, van der Worp HB, Algra A, Kappelle LJ, Rinkel GJ, van Gelder IC, Schutgens RE, Klijn CJ; APACHE-AF Investigators.

Trials. 2015 Sep 4;16:393. doi: 10.1186/s13063-015-0898-4.

5.

Improving stroke prevention in patients with atrial fibrillation.

Arts DL, Abu-Hanna A, Büller HR, Peters RJ, Eslami S, van Weert HC.

Trials. 2013 Jul 2;14:193. doi: 10.1186/1745-6215-14-193.

6.

Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial.

Holt TA, Fitzmaurice DA, Marshall T, Fay M, Qureshi N, Dalton AR, Hobbs FD, Lasserson DS, Kearley K, Hislop J, Jin J.

Trials. 2013 Nov 13;14:385. doi: 10.1186/1745-6215-14-385.

7.

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].

Mant JW, Richards SH, Hobbs FD, Fitzmaurice D, Lip GY, Murray E, Banting M, Fletcher K, Rahman J, Allan T, Raftery J, Bryan S; Midlands Research Consortium of General Practice.

BMC Cardiovasc Disord. 2003 Aug 26;3:9. Epub 2003 Aug 26.

8.

Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke.

Yoon CH, Park YK, Kim SJ, Lee MJ, Ryoo S, Kim GM, Chung CS, Lee KH, Kim JS, Bang OY.

Stroke. 2014 Oct;45(10):2983-8. doi: 10.1161/STROKEAHA.114.005599. Epub 2014 Aug 21.

9.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
10.

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.

Lane DA, Raichand S, Moore D, Connock M, Fry-Smith A, Fitzmaurice DA; Steering Committee.

Health Technol Assess. 2013 Jul;17(30):1-188. doi: 10.3310/hta17300. Review.

11.
12.

Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.

Shantsila E, Wolff A, Lip GY, Lane DA.

Br J Gen Pract. 2015 Jan;65(630):e16-23. doi: 10.3399/bjgp15X683113.

13.

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P.

Circulation. 2004 Oct 19;110(16):2287-92. Epub 2004 Oct 11.

14.

Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.

Cope S, Clemens A, Hammès F, Noack H, Jansen JP.

Value Health. 2015 Mar;18(2):234-49. doi: 10.1016/j.jval.2014.10.012. Epub 2015 Jan 28. Review.

15.
16.

HRS/NSA 2014 survey of atrial fibrillation and stroke: Gaps in knowledge and perspective, opportunities for improvement.

Frankel DS, Parker SE, Rosenfeld LE, Gorelick PB.

Heart Rhythm. 2015 Aug;12(8):e105-13. doi: 10.1016/j.hrthm.2015.04.039. Epub 2015 May 14.

PMID:
25981149
17.

Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?

Alamneh EA, Chalmers L, Bereznicki LR.

Am J Cardiovasc Drugs. 2016 Jun;16(3):183-200. doi: 10.1007/s40256-016-0161-8. Review.

PMID:
26862063
18.

Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice.

Frost L, Johnsen SP, Pedersen L, Toft E, Husted S, Sørensen HT.

J Intern Med. 2002 Jul;252(1):64-9.

19.

A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation.

Jackson SL, Peterson GM, Vial JH.

Ann Pharmacother. 2004 Nov;38(11):1794-9. Epub 2004 Sep 28.

PMID:
15454583
20.

Supplemental Content

Support Center